Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$16.26M$16.26Mderived−5.3% vs Q4 2013 Net Income$1.04M$1.04Mderived+19.9% vs Q4 2013 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$11,625,000+0.3% Operating Incomederived$2,774,000+12.8% Operating Cash Flowderived$3,051,000+13.1% Free Cash Flowderived$8,224,000+499.9% Margins · derivedGross margin71.5%+4.0 pt vs Q4 2013
Operating margin17.1%+2.7 pt vs Q4 2013
Net margin6.4%+1.3 pt vs Q4 2013
ended Dec 31, 2014 · filed Mar 9, 2015 · 68 d after period end